These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

379 related items for PubMed ID: 22120944

  • 1. Topical oxytocin reverses vaginal atrophy in postmenopausal women: a double-blind randomized pilot study.
    Jonasson AF, Edwall L, Uvnäs-Moberg K.
    Menopause Int; 2011 Dec; 17(4):120-5. PubMed ID: 22120944
    [Abstract] [Full Text] [Related]

  • 2. Role of topical oxytocin in improving vaginal atrophy in postmenopausal women: a randomized, controlled trial.
    Torky HA, Taha A, Marie H, El-Desouky E, Raslan O, Moussa AA, Ahmad AM, Abo-Louz A, Zaki S, Fares T, Eesa A.
    Climacteric; 2018 Apr; 21(2):174-178. PubMed ID: 29347848
    [Abstract] [Full Text] [Related]

  • 3. Oxytocin improves cytological and histological profiles of vaginal atrophy in postmenopausal women.
    Al-Saqi SH, Jonasson AF, Naessén T, Uvnäs-Moberg K.
    Post Reprod Health; 2016 Mar; 22(1):25-33. PubMed ID: 26883689
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Role of high molecular weight hyaluronic acid in postmenopausal vaginal discomfort.
    Grimaldi EF, Restaino S, Inglese S, Foltran L, Sorz A, Di Lorenzo G, Guaschino S.
    Minerva Ginecol; 2012 Aug; 64(4):321-9. PubMed ID: 22728576
    [Abstract] [Full Text] [Related]

  • 6. A randomized, placebo- and active-controlled trial of bazedoxifene/conjugated estrogens for treatment of moderate to severe vulvar/vaginal atrophy in postmenopausal women.
    Kagan R, Williams RS, Pan K, Mirkin S, Pickar JH.
    Menopause; 2010 Mar; 17(2):281-9. PubMed ID: 19779382
    [Abstract] [Full Text] [Related]

  • 7. The effect of oxytocin vaginal gel on vaginal atrophy in postmenopausal women: a randomized controlled trial.
    Zohrabi I, Abedi P, Ansari S, Maraghi E, Shakiba Maram N, Houshmand G.
    BMC Womens Health; 2020 May 19; 20(1):108. PubMed ID: 32429977
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Low-dose, vaginally administered estrogens may enhance local benefits of systemic therapy in the treatment of urogenital atrophy in postmenopausal women on hormone therapy.
    Palacios S, Castelo-Branco C, Cancelo MJ, Vázquez F.
    Maturitas; 2005 Feb 14; 50(2):98-104. PubMed ID: 15653006
    [Abstract] [Full Text] [Related]

  • 11. Effects of bazedoxifene/conjugated estrogens on quality of life in postmenopausal women with symptoms of vulvar/vaginal atrophy.
    Bachmann G, Bobula J, Mirkin S.
    Climacteric; 2010 Apr 14; 13(2):132-40. PubMed ID: 19863455
    [Abstract] [Full Text] [Related]

  • 12. Effect of topical oxytocin gel on vaginal mucosa in postmenopausal Egyptian women: a clinical randomized trial.
    Moussa A, Moberg KU, Elgrahy I, Elsayied M, Abdel-Rasheed M, Farouk M, Saad H, Meshaal H.
    J Sex Med; 2023 Feb 14; 20(2):177-183. PubMed ID: 36763919
    [Abstract] [Full Text] [Related]

  • 13. The therapeutic effect of a new ultra low concentration estriol gel formulation (0.005% estriol vaginal gel) on symptoms and signs of postmenopausal vaginal atrophy: results from a pivotal phase III study.
    Cano A, Estévez J, Usandizaga R, Gallo JL, Guinot M, Delgado JL, Castellanos E, Moral E, Nieto C, del Prado JM, Ferrer J.
    Menopause; 2012 Oct 14; 19(10):1130-9. PubMed ID: 22914208
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Evaluation the efficacy and safety of estradiol and drospirenone tablets in the treatment of menopausal symptoms among postmenopausal Chinese healthy women:a randomized, multi-center, double-blind, placebo-controlled clinical study].
    Zhou YZ, Sun LZ, Lin JF, Yang X, Zhang LJ, Qiao J, Wang ZH, Xu YX, Xiong ZA, Lin SQ.
    Zhonghua Fu Chan Ke Za Zhi; 2011 May 14; 46(5):345-9. PubMed ID: 21733370
    [Abstract] [Full Text] [Related]

  • 16. Open, non-controlled clinical studies to assess the efficacy and safety of a medical device in form of gel topically and intravaginally used in postmenopausal women with genital atrophy.
    Morali G, Polatti F, Metelitsa EN, Mascarucci P, Magnani P, Marrè GB.
    Arzneimittelforschung; 2006 May 14; 56(3):230-8. PubMed ID: 16618016
    [Abstract] [Full Text] [Related]

  • 17. Twice-weekly synthetic conjugated estrogens vaginal cream for the treatment of vaginal atrophy.
    Freedman M, Kaunitz AM, Reape KZ, Hait H, Shu H.
    Menopause; 2009 May 14; 16(4):735-41. PubMed ID: 19252451
    [Abstract] [Full Text] [Related]

  • 18. The effect of vaginally administered genistein in comparison with hyaluronic acid on atrophic epithelium in postmenopause.
    Le Donne M, Caruso C, Mancuso A, Costa G, Iemmo R, Pizzimenti G, Cavallari V.
    Arch Gynecol Obstet; 2011 Jun 14; 283(6):1319-23. PubMed ID: 20577750
    [Abstract] [Full Text] [Related]

  • 19. Microdose transdermal estrogen therapy for relief of vulvovaginal symptoms in postmenopausal women.
    Bachmann GA, Schaefers M, Uddin A, Utian WH.
    Menopause; 2009 Jun 14; 16(5):877-82. PubMed ID: 19458560
    [Abstract] [Full Text] [Related]

  • 20. A randomized, double-blind, placebo-controlled phase 2 pilot trial evaluating a novel, vaginal softgel capsule containing solubilized estradiol.
    Pickar JH, Amadio JM, Hill JM, Bernick BA, Mirkin S.
    Menopause; 2016 May 14; 23(5):506-10. PubMed ID: 26836245
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.